相似文献
1
Neurodegenerative diseases and transglutaminase.神经退行性疾病与转谷氨酰胺酶
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14310-3. doi: 10.1073/pnas.93.25.14310.
2
Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases: minireview article.转谷氨酰胺酶活性可能参与多聚谷氨酰胺疾病发病机制的生化机制：综述文章
Amino Acids. 2004 Jul;26(4):431-4. doi: 10.1007/s00726-004-0089-1. Epub 2004 Apr 14.
3
Role of transglutaminase-catalyzed reactions in the post-translational modifications of proteins responsible for immunological disorders.转谷氨酰胺酶催化反应在导致免疫紊乱的蛋白质翻译后修饰中的作用。
Inflamm Allergy Drug Targets. 2008 Mar;7(1):24-9. doi: 10.2174/187152808784165171.
4
Transglutaminases as possible therapeutic targets in neurodegenerative diseases.转谷氨酰胺酶作为神经退行性疾病中可能的治疗靶点。
Recent Pat CNS Drug Discov. 2010 Nov;5(3):195-202. doi: 10.2174/157488910793362430.
5
Tissue transglutaminase: a possible role in neurodegenerative diseases.组织转谷氨酰胺酶：在神经退行性疾病中的潜在作用。
Prog Neurobiol. 2000 Aug;61(5):439-63. doi: 10.1016/s0301-0082(99)00052-0.
6
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.转谷氨酰胺酶催化的神经系统中蛋白质的翻译后修饰及其在神经退行性疾病中的可能作用。
CNS Neurol Disord Drug Targets. 2008 Oct;7(4):370-5. doi: 10.2174/187152708786441821.
7
Transglutaminase and diseases of the central nervous system.转谷氨酰胺酶与中枢神经系统疾病
Front Biosci. 2005 Sep 1;10:3078-92. doi: 10.2741/1764.
8
Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.
Adv Enzymol Relat Areas Mol Biol. 2011;78:97-160. doi: 10.1002/9781118105771.ch3.
9
Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.转谷氨酰胺酶在神经系统中的作用及其在神经退行性疾病中的可能参与。
Curr Med Chem. 2009;16(36):4767-73. doi: 10.2174/092986709789909594.
10
Cellular transglutaminases in neural development.神经发育中的细胞转谷氨酰胺酶
Int J Dev Neurosci. 1993 Dec;11(6):709-20. doi: 10.1016/0736-5748(93)90060-q.
引用本文的文献
1
Amyloid-like protein inclusions in tobacco transgenic plants.烟草转基因植物中的淀粉样蛋白包涵体。
PLoS One. 2010 Oct 26;5(10):e13625. doi: 10.1371/journal.pone.0013625.
2
Aggregation of expanded huntingtin in the brains of patients with Huntington disease.亨廷顿病患者大脑中扩展型亨廷顿蛋白的聚集。
Prion. 2007 Jan-Mar;1(1):26-31. doi: 10.4161/pri.1.1.4056.
3
Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.钙调蛋白调节亨廷顿蛋白的转谷氨酰胺酶2交联。
J Neurosci. 2004 Feb 25;24(8):1954-61. doi: 10.1523/JNEUROSCI.4424-03.2004.
4
Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.肌萎缩侧索硬化症药物治疗的前景：第三个千年的旧策略与新范式
CNS Drugs. 2003;17(10):699-717. doi: 10.2165/00023210-200317100-00002.
5
Transglutaminase type II plays a protective role in hepatic injury.组织转谷氨酰胺酶II在肝损伤中发挥保护作用。
Am J Pathol. 2003 Apr;162(4):1293-303. doi: 10.1016/S0002-9440(10)63925-9.
6
Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity.组织转谷氨酰胺酶鸟嘌呤核苷酸结合活性的结构基础及其对转酰胺基活性的调控
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2743-7. doi: 10.1073/pnas.042454899. Epub 2002 Feb 26.
7
Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.转谷氨酰胺酶将亨廷顿蛋白聚集成非淀粉样生成聚合物，且其酶活性在亨廷顿病脑细胞核中增强。
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7388-93. doi: 10.1073/pnas.96.13.7388.
8
Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.转谷氨酰胺酶催化甘油醛-3-磷酸脱氢酶和α-酮戊二酸脱氢酶复合物被病理性长度的聚谷氨酰胺结构域灭活。
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12604-9. doi: 10.1073/pnas.94.23.12604.
本文引用的文献
1
Amine incorporation into insulin as catalyzed by transglutaminase.转谷氨酰胺酶催化胺掺入胰岛素。
Arch Biochem Biophys. 1959 Oct;84:528-40. doi: 10.1016/0003-9861(59)90613-7.
2
Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.含谷氨酰胺重复序列的肽作为转谷氨酰胺酶催化交联的底物：与神经系统疾病的相关性。
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14580-5. doi: 10.1073/pnas.93.25.14580.
3
Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease.在亨廷顿病患者中，转谷氨酰胺酶活性与CAG重复序列长度相关。
Hum Genet. 1996 Dec;98(6):633-5. doi: 10.1007/s004390050273.
4
Alterations in neural intermediate filament organization: functional implications and the induction of pathological changes related to motor neuron disease.神经中间丝组织的改变：功能影响及与运动神经元疾病相关的病理变化诱导
J Cell Sci. 1996 Sep;109 ( Pt 9):2319-29. doi: 10.1242/jcs.109.9.2319.
5
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.转基因小鼠中的相关记忆缺陷、β-淀粉样蛋白升高和淀粉样斑块。
Science. 1996 Oct 4;274(5284):99-102. doi: 10.1126/science.274.5284.99.
6
Immunohistochemical detection of coagulation factor XIIIa in postmortem human brain tissue.人死后脑组织中凝血因子XIIIa的免疫组织化学检测
Neurosci Lett. 1995 Dec 29;202(1-2):29-32. doi: 10.1016/0304-3940(95)12188-9.
7
Amyloid beta-protein and the genetics of Alzheimer's disease.淀粉样β蛋白与阿尔茨海默病的遗传学
J Biol Chem. 1996 Aug 2;271(31):18295-8. doi: 10.1074/jbc.271.31.18295.
8
Purification and characterization of rat brain transglutaminase.大鼠脑转谷氨酰胺酶的纯化与特性分析
J Biochem. 1995 Dec;118(6):1271-8. doi: 10.1093/oxfordjournals.jbchem.a125018.
9
Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling.磷脂酶δ1是组织转谷氨酰胺酶II（Gh）介导信号传导中的效应器的证据。
J Biol Chem. 1996 Jul 12;271(28):16451-4. doi: 10.1074/jbc.271.28.16451.
10
Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase.亨廷顿蛋白相关蛋白1（HAP1）：在大脑中离散的神经元定位类似于神经元型一氧化氮合酶的定位。
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4839-44. doi: 10.1073/pnas.93.10.4839.
Zotero 插件